• 产品名称Anti-Bradykinin抗体
    参阅全部 Bradykinin 一抗
  • 描述
    兔多克隆抗体to Bradykinin
  • 特异性Bradykinin: 100%. Although the immunogen for this antibody was the 9-amino acid peptide, bradykinin, conjugated to BSA the antibody recognizes both free and endogenous bradykinin in ELISA.
  • 经测试应用适用于: ELISAmore details
  • 种属反应性
    与反应: Human
  • 免疫原

    Full length protein (Human) conjugated to BSA.

  • 常规说明For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer. Supplied as a liquid serum, 40% glycerol



Our Abpromise guarantee covers the use of ab14391 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

应用 Ab评论 说明
ELISA 1/250 - 1/500.


  • 功能(1) Kininogens are inhibitors of thiol proteases; (2) HMW-kininogen plays an important role in blood coagulation by helping to position optimally prekallikrein and factor XI next to factor XII; (3) HMW-kininogen inhibits the thrombin- and plasmin-induced aggregation of thrombocytes; (4) the active peptide bradykinin that is released from HMW-kininogen shows a variety of physiological effects: (4A) influence in smooth muscle contraction, (4B) induction of hypotension, (4C) natriuresis and diuresis, (4D) decrease in blood glucose level, (4E) it is a mediator of inflammation and causes (4E1) increase in vascular permeability, (4E2) stimulation of nociceptors (4E3) release of other mediators of inflammation (e.g. prostaglandins), (4F) it has a cardioprotective effect (directly via bradykinin action, indirectly via endothelium-derived relaxing factor action); (5) LMW-kininogen inhibits the aggregation of thrombocytes; (6) LMW-kininogen is in contrast to HMW-kininogen not involved in blood clotting.
  • 组织特异性Secreted in plasma. T-kinin is detected in malignant ovarian, colon and breast carcinomas, but not in benign tumors.
  • 疾病相关Defects in KNG1 are the cause of high molecular weight kininogen deficiency (HMWK deficiency) [MIM:228960]. HMWK deficiency is an autosomal recessive coagulation defect. Patients with HWMK deficiency do not have a hemorrhagic tendency, but they exhibit abnormal surface-mediated activation of fibrinolysis.
  • 序列相似性Contains 3 cystatin domains.
  • 翻译后修饰Bradykinin is released from kininogen by plasma kallikrein.
    Hydroxylation of Pro-383 occurs prior to the release of bradykinin.
    Phosphorylation sites are present in the extracelllular medium.
    N- and O-glycosylated. O-glycosylated with core 1 or possibly core 8 glycans.
  • 细胞定位Secreted > extracellular space.
  • Information by UniProt
  • 数据库链接
  • 别名
    • Alpha-2-thiol proteinase inhibitor antibody
    • BDK antibody
    • Fitzgerald factor antibody
    • High molecular weight kininogen antibody
    • HMWK antibody
    • Ile-Ser-Bradykinin antibody
    • Kallidin I antibody
    • Kallidin II antibody
    • Kininogen 1 antibody
    • KNG antibody
    • KNG1 antibody
    • KNG1_HUMAN antibody
    • Low molecular weight growth-promoting factor antibody
    • Williams-Fitzgerald-Flaujeac factor antibody
    see all

Anti-Bradykinin antibody (ab14391)参考文献

ab14391 has not yet been referenced specifically in any publications.

Product Wall

Thank you for your inquiry.

I can confirm that ab14391 recognizes Lys-Bradykinin (Kallidin).

It does not recognize [Des-Arg9]-Bradykinin.

The characterization of this antibody was performed by RIA.

I hope this in...

Read More

Thank you for your inquiry.

For the three of our bradykinin antibodies, ab47864, ab14391and ab47686, the immunogen used was from a.a. 381- 389 of the human sequence (RPPGFSPFR).

You can see any testing information on the online data...

Read More

Thank you for contacting us. This antibody has not been tested for neutralizing capability in cell culture and so we can not speak to its potential in that use. I hope this information is helpful to you. Please do not hesitate to contact us if you...

Read More